Sun Pharma Advanced Research Co

216.47
+12.32
(6.03%)
comparison:

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
43
44
43
34
44
25
99
26
45
25
16
22
70
18
66
23
89
21
20
20
26
186
21
23
28
22
33
63
26
29
32
131
58
34
30
20
21
18
13
Expenses
51
43
59
73
50
57
81
90
75
101
77
78
65
81
67
90
97
112
80
73
121
125
100
85
79
76
83
73
92
107
94
115
137
126
113
117
124
112
117
EBITDA
-8
0
-16
-39
-6
-33
18
-64
-30
-77
-61
-56
5
-63
-1
-67
-8
-91
-61
-53
-95
61
-80
-61
-50
-54
-49
-11
-66
-78
-63
16
-79
-92
-83
-96
-103
-94
-104
Operating Profit %
-19 %
0 %
-37 %
-116 %
-21 %
-167 %
14 %
-290 %
-81 %
-333 %
-400 %
-300 %
-224 %
-379 %
-8 %
-354 %
-14 %
-549 %
-366 %
-274 %
-433 %
33 %
-467 %
-289 %
-180 %
-245 %
-196 %
-18 %
-264 %
-275 %
-198 %
12 %
-188 %
-427 %
-432 %
-740 %
-649 %
-566 %
-808 %
Depreciation
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Interest
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
2
2
1
4
4
5
3
2
2
2
3
3
0
0
0
0
1
1
1
Profit Before Tax
-9
-2
-18
-41
-10
-36
15
-66
-32
-79
-63
-58
3
-65
-3
-69
-9
-94
-63
-56
-100
57
-84
-68
-57
-61
-55
-16
-71
-82
-68
10
-82
-95
-86
-100
-107
-97
-108
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-9
-2
-18
-41
-10
-36
15
-66
-32
-79
-63
-58
3
-65
-3
-69
-9
-94
-63
-56
-100
57
-84
-68
-57
-61
-55
-16
-71
-82
-68
10
-82
-95
-86
-100
-107
-97
-108
EPS in ₹
-0.40
-0.07
-0.75
-1.73
-0.40
-1.46
0.61
-2.67
-1.30
-3.19
-2.53
-2.34
0.10
-2.57
-0.10
-2.72
-0.37
-3.59
-2.41
-2.12
-3.80
2.16
-3.19
-2.58
-2.16
-2.34
-2.09
-0.60
-2.69
-3.03
-2.52
0.37
-2.55
-2.94
-2.66
-3.07
-3.29
-2.98
-3.32

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
143
163
273
309
399
273
230
280
830
486
Fixed Assets
67
70
69
52
58
104
91
92
106
103
Current Assets
63
67
158
175
257
67
63
71
455
246
Capital Work in Progress
0
1
2
3
24
32
5
26
27
44
Investments
0
0
10
108
211
9
6
12
291
2
Other Assets
76
92
192
146
106
128
128
150
407
338
Total Liabilities
143
163
273
309
399
273
230
280
830
486
Current Liabilities
37
125
108
116
95
235
233
171
179
244
Non Current Liabilities
6
6
6
8
7
56
165
77
138
118
Total Equity
100
32
158
185
296
-19
-168
31
513
125
Reserve & Surplus
76
6
134
68
270
-45
-195
-230
480
92
Share Capital
24
24
25
25
26
26
26
27
33
33

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
11
-7
60
-63
0
0
9
-8
-1
5
Investing Activities
53
-13
-7
-105
-102
155
2
-29
-548
391
Operating Activities
-41
-44
-128
-183
-172
-211
-152
-208
-69
-429
Financing Activities
-1
51
194
224
274
56
159
229
617
43

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
68.46 %
68.46 %
68.10 %
68.10 %
69.09 %
69.09 %
69.09 %
68.22 %
65.67 %
65.67 %
65.67 %
65.67 %
65.67 %
65.67 %
65.67 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.30 %
3.23 %
2.64 %
2.15 %
DIIs
0.01 %
0.02 %
0.02 %
0.02 %
0.24 %
0.24 %
0.24 %
0.93 %
0.78 %
0.78 %
0.23 %
0.81 %
0.82 %
0.18 %
0.23 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
18.08 %
18.00 %
16.91 %
16.94 %
14.73 %
16.45 %
15.70 %
16.00 %
16.18 %
16.13 %
15.90 %
16.09 %
16.11 %
18.91 %
19.20 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
216.47 6,624.70 - 105.00 -57.95 -387 -24.19 57.69

Corporate Action

Technical Indicators

RSI(14)
Neutral
57.69
ATR(14)
Volatile
8.90
STOCH(9,6)
Neutral
71.89
STOCH RSI(14)
Overbought
87.45
MACD(12,26)
Bullish
1.58
ADX(14)
Weak Trend
16.37
UO(9)
Bearish
50.70
ROC(12)
Uptrend And Accelerating
4.66
WillR(14)
Overbought
-11.67